Periarticular Knee Injection With Liposomal Bupivacaine and Continuous Femoral Nerve Block for Postoperative Pain Management After Total Knee Arthroplasty: A Randomized Controlled Trial.

[1]  M. Maltenfort,et al.  How Much Pain Is Significant? Defining the Minimal Clinically Important Difference for the Visual Analog Scale for Pain After Total Joint Arthroplasty. , 2018, The Journal of arthroplasty.

[2]  S. Odum,et al.  Systemic Safety of Liposomal Bupivacaine in Simultaneous Bilateral Total Knee Arthroplasty. , 2018, The Journal of arthroplasty.

[3]  Ken Johnson,et al.  Serum Bupivacaine Concentration After Periarticular Injection With a Mixture of Liposomal Bupivacaine and Bupivacaine HCl During Total Knee Arthroplasty , 2017, Regional Anesthesia & Pain Medicine.

[4]  Cheng-wei Weng,et al.  Comparison of periarticular anesthesia with liposomal bupivacaine with femoral nerve block for pain control after total knee arthroplasty , 2017, Medicine.

[5]  A. Sinha,et al.  Role of Periarticular Liposomal Bupivacaine Infiltration in Patients Undergoing Total Knee Arthroplasty-A Meta-analysis of Comparative Trials. , 2017, The Journal of arthroplasty.

[6]  J. Bosco,et al.  Pain Control and Functional Milestones in Total Knee Arthroplasty: Liposomal Bupivacaine versus Femoral Nerve Block , 2017, Clinical orthopaedics and related research.

[7]  S. Sporer,et al.  Postoperative Pain Management After Primary Total Knee Arthroplasty: The Value of Liposomal Bupivacaine. , 2016, The Journal of arthroplasty.

[8]  P. Maurer,et al.  Assessment of liposome bupivacaine infiltration versus continuous femoral nerve block for postsurgical analgesia following total knee arthroplasty: a retrospective cohort study , 2016, Current medical research and opinion.

[9]  J. Gadsden,et al.  Time to Analgesia Onset and Pharmacokinetics After Separate and Combined Administration of Liposome Bupivacaine and Bupivacaine HCl: Considerations for Clinicians , 2016, The open orthopaedics journal.

[10]  Heather N. Watson,et al.  Femoral Nerve Block Versus Long-Acting Wound Infiltration in Total Knee Arthroplasty. , 2016, Orthopedics.

[11]  P. Pathak,et al.  Femoral Nerve Block vs Periarticular Bupivacaine Liposome Injection After Primary Total Knee Arthroplasty: Effect on Patient Outcomes , 2015, The Journal of the American Osteopathic Association.

[12]  J. Dasta,et al.  Evolving Role of Local Anesthetics in Managing Postsurgical Analgesia. , 2015, Clinical therapeutics.

[13]  J. Surdam,et al.  The use of exparel (liposomal bupivacaine) to manage postoperative pain in unilateral total knee arthroplasty patients. , 2015, The Journal of arthroplasty.

[14]  J. Popovich,et al.  Comparison Between Liposomal Bupivacaine and Femoral Nerve Block in Patients Undergoing Primary Total Knee Arthroplasty. , 2015, Journal of surgical orthopaedic advances.

[15]  G. Scuderi**,et al.  Periarticular regional analgesia in total knee arthroplasty: a review of the neuroanatomy and injection technique. , 2015, The Orthopedic clinics of North America.

[16]  Brian Burnikel,et al.  Novel strategies to improve early outcomes following total knee arthroplasty: a case control study of intra articular injection versus femoral nerve block , 2014, International Orthopaedics.

[17]  C. Peters,et al.  Postoperative falls after total knee arthroplasty in patients with a femoral nerve catheter: can we reduce the incidence? , 2014, The Journal of arthroplasty.

[18]  C. Oatis,et al.  Patient-reported outcomes after total knee replacement vary on the basis of preoperative coexisting disease in the lumbar spine and other nonoperatively treated joints: the need for a musculoskeletal comorbidity index. , 2013, The Journal of bone and joint surgery. American volume.

[19]  V. Araújo-Soares,et al.  Persistent pain after total knee or hip arthroplasty: differential study of prevalence, nature, and impact , 2013, Journal of pain research.

[20]  F. Savoie,et al.  Liposomal extended-release bupivacaine for postsurgical analgesia , 2013, Patient preference and adherence.

[21]  N. Mahomed,et al.  Advanced age, obesity and continuous femoral nerve blockade are independent risk factors for inpatient falls after primary total knee arthroplasty. , 2013, The Journal of arthroplasty.

[22]  R. Gandhi,et al.  The Impact of Analgesic Modality on Early Ambulation Following Total Knee Arthroplasty , 2013, Regional Anesthesia & Pain Medicine.

[23]  A. Hadžić,et al.  Pharmacokinetic Profile of Liposome Bupivacaine Injection Following a Single Administration at the Surgical Site , 2013, Clinical Drug Investigation.

[24]  P. White,et al.  A Double-Blind, Randomized, Active-Controlled Study for Post-Hemorrhoidectomy Pain Management with Liposome Bupivacaine, a Novel Local Analgesic Formulation , 2012, The American surgeon.

[25]  Rachael Gooberman-Hill,et al.  What proportion of patients report long-term pain after total hip or knee replacement for osteoarthritis? A systematic review of prospective studies in unselected patients , 2012, BMJ Open.

[26]  S. Daniels,et al.  A phase 3, randomized, placebo-controlled trial of DepoFoam® bupivacaine (extended-release bupivacaine local analgesic) in bunionectomy , 2011, Advances in therapy.

[27]  A. Blom,et al.  Acute postoperative pain at rest after hip and knee arthroplasty: severity, sensory qualities and impact on sleep. , 2011, Orthopaedics & traumatology, surgery & research : OTSR.

[28]  R. Sinatra.  Causes and consequences of inadequate management of acute pain. , 2010, Pain medicine.

[29]  L. Specht,et al.  Complications of Femoral Nerve Block for Total Knee Arthroplasty , 2010, Clinical orthopaedics and related research.

[30]  D. Kerr,et al.  Local infiltration analgesia: a technique for the control of acute postoperative pain following knee and hip surgery: A case study of 325 patients , 2008, Acta orthopaedica.

[31]  L. Nikolajsen,et al.  Comparison of peri- and intraarticular analgesia with femoral nerve block after total knee arthroplasty: A randomized clinical trial , 2007, Acta orthopaedica.

[32]  P. Choong,et al.  Continuous Femoral Nerve Blockade or Epidural Analgesia After Total Knee Replacement: A Prospective Randomized Controlled Trial , 2005, Anesthesia and analgesia.

[33]  S. Mantripragada.  A lipid based depot (DepoFoam technology) for sustained release drug delivery. , 2002, Progress in lipid research.

[34]  H. Kehlet,et al.  Multimodal strategies to improve surgical outcome. , 2002, American journal of surgery.

[35]  R. Sinatra,et al.  Pain management after major orthopaedic surgery: current strategies and new concepts. , 2002, The Journal of the American Academy of Orthopaedic Surgeons.

[36]  X. Capdevila,et al.  Effects of perioperative analgesic technique on the surgical outcome and duration of rehabilitation after major knee surgery. , 1999, Anesthesiology.

[37]  R. Gristwood,et al.  A comparison of the cardiovascular effects of levobupivacaine and rac-bupivacaine following intravenous administration to healthy volunteers. , 2002, British journal of clinical pharmacology.

[38]  C. Olofsson,et al.  Pharmacokinetics and clinical effect during continuous epidural infusion with ropivacaine 2.5 mg/ml or bupivacaine 2.5 mg/ml for labour pain relief , 1998, Acta anaesthesiologica Scandinavica.

[39]  F. Singelyn,et al.  Effects of Intravenous Patient-Controlled Analgesia with Morphine, Continuous Epidural Analgesia, and Continuous Three-in-One Block on Postoperative Pain and Knee Rehabilitation After Unilateral Total Knee Arthroplasty , 1998, Anesthesia and analgesia.

[40]  K. Todd,et al.  Clinical significance of reported changes in pain severity. , 1996, Annals of emergency medicine.